MBX Biosciences (MBX) announced the appointment of Andreas Moraitis, M.D., as Senior Vice President of Clinical Development. Prior to joining MBX, Dr. Moraitis spent over a decade at Corcept Therapeutics, where he oversaw endocrine clinical development.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks